Table: begin end state 1 31 cytoplasmic 32 56 transmembrane 57 207 non-cytoplasmic 208 232 transmembrane 233 242 cytoplasmic 243 266 transmembrane 267 294 non-cytoplasmic 295 315 transmembrane 316 348 cytoplasmic 349 371 transmembrane 372 390 non-cytoplasmic 391 414 transmembrane 415 425 cytoplasmic
Input: >BPHYT_RS34090 FitnessBrowser__BFirm:BPHYT_RS34090 MTTITIAADSTPESSGRLKRELKAAEARKRAMALLLIAPLAIFLLLIFVVPIGALLTRAA QNPEVVNALPHTVASLSAWDRKTPPPDTAYTALAVDLAAIADSDGMGALARRLNVEIPGY RSLVAKSARAMPFVDDNSKPLQLTPAQMHAKFAELDERWNDIAYWQAIAKNAGAYSPFYL LASLDHKQDAFGHIIPTDPDQQIYLAVFSRTFVIGAAVTFFALLLGYPLAYWISTLSERR ANLVMILVLIPFWTSILVRVAAWIVILQSEGLVNKALIGSGLLHDPLALLFNRTGVYISM THILLPFMILPLYSVMKSIPPTYQRAAISLGSHPFAAFWRVYVPQTYPGIGAGALLVFIL AIGYYITPALLGGPNDQMVSYYVAYFTNVTINWGMACALGGLLLAATLVLYVIYGRFTRS SLSLG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server